Medical Cannabis The Science. The Research. The Risk.

February 28, 2020

“Medical Cannabis: The science. The research. The risks.” is a full spectrum education program for the medical community. This conference held on November 15th, 2019 in New York focuses on the scientific and legal knowledge of healthcare professionals (physicians, pharmacists, physician assistants, nurse practitioners) and medical legal professionals. Anyone who wants to learn more about the science and potential liability surrounding cannabis will benefit from it.

CE | CME 5.75 Credits $249.00 USD

Narcolepsy and Excessive Daytime Sleepiness in OSA: Strategies to Improving Outcomes

January 26, 2020

In this program, sleep experts Dr. Richard Bogan (Chair), Dr. Yves Dauvilliers, Dr. Kiran Maski, Dr. Paula Schweitzer, and Dr. Michael Thorpy assess traditional and new therapies for treating patients with narcolepsy and EDS in OSA.

CME 2.00 Credits

Narcolepsy in Children: Addressing the Challenges and Improving the Outcomes

January 04, 2020

In this program, pediatric sleep disorder experts Kiran Maski, MD, MPH; Judith Owens, MD, MPH, and Michael Strunc, MD will describe best practices in diagnosis and treatment of narcolepsy.

CME 1.50 Credits

Tailoring LDL-C-Lowering Therapy to Patient Cardiovascular Risk: Identifying Effective Strategies for Patients with Diabetes

November 30, 2019

In this program, a panel of experts will discuss the latest guidelines for managing LDL-C in patients with diabetes, interpret data with nonstatin, LDL-C-lowering therapies, describe improving access to PCSK9 inhibitors and tips for achieving earlier access,

CME 2.00 Credits

Using Narcolepsy Medications Wisely: Tips for Clinical Practice

October 16, 2019

Audio presentations on the considerations and treatment options for the management of Narcolepsy

CE | CME 1.00 Credits

Narcolepsy in Children: Overcoming Barriers and Improving Outcomes

October 04, 2019

Narcolepsy in Children

CME 1.00 Credits

Reducing LDL-C and Cardiovascular Risk with Nonstatin Therapy: From Evidence to Practice

July 02, 2019

In this symposium, lipid experts Dr. Robert Giugliano, Dr. Marc Sabatine, and Dr. James Underberg will describe best practices for internists in managing LDL-C and reducing the risk for major cardiovascular events with the addition of nonstatin therapy.

CME 2.00 Credits

Managing LDL-C to Reduce Cardiovascular Disease Risk: Defining Best Clinical Practice

April 22, 2019

In this program, an expert faculty will discuss the evidence and recommendations for managing LDL-C in patients with ASCVD, familial hypercholesterolemia (FH), diabetes, and those at increased cardiovascular risk without ASCVD.

CME 2.00 Credits

CROSSROADS OF CARE: Facing the Challenges of Heart Failure and Diabetes

April 01, 2019

In this symposium, Dr. James Januzzi and Dr. Mikhail Kosiborod will explain the intertwined relationship between diabetes and HF, and interpret safety and effi cacy data, focusing on HF-related outcomes, from studies with diabetes therapies.

CME 1.00 Credits

Hyperkalemia and Heart Failure: Recognizing Risks and Exploring Strategies for Improving Outcomes

February 24, 2019

In this program, Dr. Paul Hauptman and Dr. Javed Butler will 1) describe the relationship between RAAS inhibitors, hyperkalemia, and cardiovascular risk, 2) identify goals and treatments for acute, intermediate, and chronic management, and 3) discuss the clinical profi les of, and clinical settings for the use of, new potassium binders.

No Credit Available

Narcolepsy in Children: Insights into Diagnosis and Strategies to Improve Patient Care

December 30, 2018

In this program, pediatric sleep disorder experts Dr. Kiran Maski and Dr. Merrill Wise will describe strategies to overcome barriers in diagnosing narcolepsy in children, and explain best practices in treatment including emerging evidence with pharmacologic therapy.

No Credit Available